Treatment of diseases of the testes affecting growth and development.
D000293:Adolescent; D013734:Androgen-Insensitivity Syndrome; D000728:Androgens / Q000378:metabolism / Q000627:therapeutic use; D001927:Brain Diseases / Q000150:complications; D002648:Child; D012734:Disorders of Sex Development / Q000188:drug therapy; D004958:Estradiol / Q000627:therapeutic use; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D005474:Fluoxymesterone / Q000627:therapeutic use; D006062:Gonadotropins / Q000627:therapeutic use; D006128:Growth; D006801:Humans; D008297:Male; D008661:Metabolism, Inborn Errors / Q000188:drug therapy; D008777:Methyltestosterone / Q000627:therapeutic use; D011627:Puberty; D011629:Puberty, Precocious / Q000188:drug therapy; D013733:Testicular Diseases / Q000188:drug therapy*; D013736:Testicular Neoplasms / Q000188:drug therapy; D013739:Testosterone / Q000378:metabolism / Q000627:therapeutic use
D000728:Androgens; D004966:Estrogens, Conjugated (USP); D006062:Gonadotropins; D013739:Testosterone; D004958:Estradiol; D005474:Fluoxymesterone; D008777:Methyltestosterone